Vometa FT
Indication
- Acute nausea and vomiting. Not recommended for the routine prevention of postoperative vomiting.
- Nausea and vomiting caused by levodopa and bromocriptine. It is recommended that treatment with domperidone should not exceed a period of 12 weeks.
- Symptomatic treatment for functional dyspepsia. Not recommended for long-term treatment.
- Acute nausea and vomiting caused by cancer chemotherapy and radiotherapy.
Composition
Domperidone 10 mg
Package
5 blisters of 10 dispersible tablets
Dosage Forms
ATC Classification
A03F
Warning
Alcohol
Consult Your Doctor
Safety of this item for use with alcohol has not been established. Please consult your doctor.
Machinery
Safe if Prescribed
This item is safe for use while operating heavy machinery.
Pregnancy
Caution
This item may not be safe for use during pregnancy. Use with caution and after consultation with your doctor.
Lactation
Caution
This item may not be safe for use during lactation. Use with caution and after consultation with your doctor.
Dosage
18 Years Old and Above
Functional dyspepsia:
10-20 mg, 3 times daily and 10-20 mg before bedtime, depending on clinical response. The treatment should not exceed 12 weeks.
Nausea and vomiting (including caused by levodopa and bromocriptine):
10-20 mg, with 4-8 hours interval.
Up to 18 Years
0.2-0.4 mg/kg body weight/day with 4-8 hours interval.
Instructions
Drug should be taken 15-30 minutes before meals and before bedtime. Vometa FT in the form of fast-melting tablet, can be swallowed without water.
Associated with Cancer-related Chemotherapy and Radiotherapy
0.2-0.4 mg/kg body weight/day with 4-8 hours interval.